These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

406 related items for PubMed ID: 19616609

  • 1. Investigation of preparation parameters to improve the dissolution of poorly water-soluble meloxicam.
    Ambrus R, Kocbek P, Kristl J, Sibanc R, Rajkó R, Szabó-Révész P.
    Int J Pharm; 2009 Nov 03; 381(2):153-9. PubMed ID: 19616609
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Development of oral lyophilisates containing meloxicam nanocrystals using QbD approach.
    Iurian S, Bogdan C, Tomuță I, Szabó-Révész P, Chvatal A, Leucuța SE, Moldovan M, Ambrus R.
    Eur J Pharm Sci; 2017 Jun 15; 104():356-365. PubMed ID: 28435075
    [Abstract] [Full Text] [Related]

  • 4. Utilization of spray drying technique for improvement of dissolution and anti-inflammatory effect of Meloxicam.
    Shazly G, Badran M, Zoheir K, Alomrani A.
    Pak J Pharm Sci; 2015 Jan 15; 28(1):103-11. PubMed ID: 25553688
    [Abstract] [Full Text] [Related]

  • 5. Investigation of preparation parameters of nanosuspension by top-down media milling to improve the dissolution of poorly water-soluble glyburide.
    Singh SK, Srinivasan KK, Gowthamarajan K, Singare DS, Prakash D, Gaikwad NB.
    Eur J Pharm Biopharm; 2011 Aug 15; 78(3):441-6. PubMed ID: 21439378
    [Abstract] [Full Text] [Related]

  • 6. Investigation of nanosized crystalline form to improve the oral bioavailability of poorly water soluble cilostazol.
    Miao X, Sun C, Jiang T, Zheng L, Wang T, Wang S.
    J Pharm Pharm Sci; 2011 Aug 15; 14(2):196-214. PubMed ID: 21733409
    [Abstract] [Full Text] [Related]

  • 7. Systematical Investigation of Different Drug Nanocrystal Technologies to Produce Fast Dissolving Meloxicam Tablets.
    Liu T, Yao G, Zhang X, Zuo X, Wang L, Yin H, Möschwitzer JP.
    AAPS PharmSciTech; 2018 Feb 15; 19(2):783-791. PubMed ID: 29019059
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A quality-by-design study to develop Nifedipine nanosuspension: examining the relative impact of formulation variables, wet media milling process parameters and excipient variability on drug product quality attributes.
    Patel PJ, Gajera BY, Dave RH.
    Drug Dev Ind Pharm; 2018 Dec 15; 44(12):1942-1952. PubMed ID: 30027778
    [Abstract] [Full Text] [Related]

  • 11. Formulation strategy and evaluation of nanocrystal piroxicam orally disintegrating tablets manufacturing by freeze-drying.
    Lai F, Pini E, Corrias F, Perricci J, Manconi M, Fadda AM, Sinico C.
    Int J Pharm; 2014 Jun 05; 467(1-2):27-33. PubMed ID: 24680963
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Self nanoemulsifying granules (SNEGs) of meloxicam: preparation, characterization, molecular modeling and evaluation of in vivo anti-inflammatory activity.
    Parekh VJ, Desai ND, Shaikh MS, Shinde UA.
    Drug Dev Ind Pharm; 2017 Apr 05; 43(4):600-610. PubMed ID: 28005437
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of inclusion complexation of meloxicam with β-cyclodextrin- and β-cyclodextrin-based nanosponges on solubility, in vitro release and stability studies.
    Shende PK, Gaud RS, Bakal R, Patil D.
    Colloids Surf B Biointerfaces; 2015 Dec 01; 136():105-10. PubMed ID: 26364091
    [Abstract] [Full Text] [Related]

  • 17. Analysis of co-spray-dried meloxicam-mannitol systems containing crystalline microcomposites.
    Pomázi A, Ambrus R, Sipos P, Szabó-Révész P.
    J Pharm Biomed Anal; 2011 Sep 10; 56(2):183-90. PubMed ID: 21652159
    [Abstract] [Full Text] [Related]

  • 18. Dermal flurbiprofen nanosuspensions: Optimization with design of experiment approach and in vitro evaluation.
    Oktay AN, Karakucuk A, Ilbasmis-Tamer S, Celebi N.
    Eur J Pharm Sci; 2018 Sep 15; 122():254-263. PubMed ID: 29981401
    [Abstract] [Full Text] [Related]

  • 19. Preparation and solidification of redispersible nanosuspensions.
    Zhang X, Guan J, Ni R, Li LC, Mao S.
    J Pharm Sci; 2014 Jul 15; 103(7):2166-2176. PubMed ID: 24840928
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.